Eledon Pharmaceuticals, Inc. Basic Shares Outstanding (Weighted Average)
Eledon Pharmaceuticals, Inc. (ELDN) reported Basic Shares Outstanding (Weighted Average) of 113.63 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- Eledon Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 113.63M shares, a 47.27% increase year-over-year.
- Eledon Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 112.42M shares, a 45.77% increase year-over-year.
- Eledon Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 95.91M shares, a 37.31% increase year-over-year.
- Eledon Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 77.16M shares, a 48.53% increase year-over-year.
- Eledon Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 81.84M shares, a 68.58% increase from fiscal 2024.
- Eledon Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 48.54M shares, a 97.18% increase from fiscal 2023.
- Eledon Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 24.62M shares, a 72.34% increase from fiscal 2022.
- Eledon Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 14.29M shares, a 3.61% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 113.63M shares 10-Q · filed 2026-08-13 | 113.03M shares 10-Q · filed 2026-08-13 | 107.32M shares derived: average of 3 quarters · filed 2026-08-13 | 99.78M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 112.42M shares 10-Q · filed 2026-05-13 | 104.16M shares derived: average of 2 quarters · filed 2026-05-13 | 95.16M shares derived: average of 3 quarters · filed 2026-05-13 | 90.66M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | 95.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 86.53M shares derived: average of 2 quarters · filed 2026-03-19 | 83.41M shares derived: average of 3 quarters · filed 2026-08-13 | 81.84M shares 10-K · filed 2026-03-19 |
| 2025-09-30 | 77.16M shares 10-Q · filed 2025-11-14 | 77.16M shares derived: average of 2 quarters · filed 2026-08-13 | 77.15M shares 10-Q · filed 2025-11-14 | 75.32M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | 77.16M shares 10-Q · filed 2026-08-13 | 77.14M shares 10-Q · filed 2026-08-13 | 74.71M shares derived: average of 3 quarters · filed 2026-08-13 | 69.02M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 77.13M shares 10-Q · filed 2026-05-13 | 73.49M shares derived: average of 2 quarters · filed 2026-05-13 | 66.31M shares derived: average of 3 quarters · filed 2026-05-13 | 60.30M shares derived: average of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | 69.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 60.90M shares derived: average of 2 quarters · filed 2026-03-19 | 54.69M shares derived: average of 3 quarters · filed 2026-03-19 | 48.54M shares 10-K · filed 2026-03-19 |
| 2024-09-30 | 51.95M shares 10-Q · filed 2025-11-14 | 47.11M shares derived: average of 2 quarters · filed 2025-11-14 | 41.44M shares 10-Q · filed 2025-11-14 | 38.56M shares derived: average of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | 42.28M shares 10-Q · filed 2025-08-14 | 36.13M shares 10-Q · filed 2025-08-14 | 34.10M shares derived: average of 3 quarters · filed 2025-08-14 | 33.07M shares derived: average of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | 29.99M shares 10-Q/A · filed 2025-08-14 | 30.01M shares derived: average of 2 quarters · filed 2025-08-14 | 30.00M shares derived: average of 3 quarters · filed 2025-08-14 | 28.50M shares derived: average of 4 quarters · filed 2025-08-14 |
| 2023-12-31 | 30.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 30.01M shares derived: average of 2 quarters · filed 2025-03-20 | 28.01M shares derived: average of 3 quarters · filed 2025-03-20 | 24.62M shares 10-K · filed 2025-03-20 |
| 2023-09-30 | 29.97M shares 10-Q · filed 2024-11-12 | 26.99M shares derived: average of 2 quarters · filed 2024-11-12 | 22.81M shares 10-Q · filed 2024-11-12 | 20.63M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 24.01M shares 10-Q · filed 2024-08-19 | 19.17M shares 10-Q · filed 2024-08-19 | 17.52M shares derived: average of 3 quarters · filed 2024-08-19 | 16.71M shares derived: average of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | 14.29M shares 10-Q/A · filed 2024-08-19 | 14.28M shares derived: average of 2 quarters · filed 2024-08-19 | 14.27M shares derived: average of 3 quarters · filed 2024-08-19 | 14.27M shares derived: average of 4 quarters · filed 2024-08-19 |
| 2022-12-31 | 14.27M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-19 | 14.27M shares derived: average of 2 quarters · filed 2024-08-19 | 14.27M shares derived: average of 3 quarters · filed 2024-08-19 | 14.29M shares 10-K/A · filed 2024-08-19 |
| 2022-09-30 | 14.27M shares 10-Q · filed 2023-11-09 | 14.27M shares derived: average of 2 quarters · filed 2023-11-09 | 14.29M shares 10-Q · filed 2023-11-09 | 14.42M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 14.27M shares 10-Q · filed 2023-08-10 | 14.30M shares 10-Q · filed 2023-08-10 | 14.47M shares derived: average of 3 quarters · filed 2023-08-10 | 14.56M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 14.33M shares 10-Q · filed 2023-05-11 | 14.57M shares derived: average of 2 quarters · filed 2023-05-11 | 14.65M shares derived: average of 3 quarters · filed 2023-05-11 | 14.69M shares derived: average of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | 14.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 14.82M shares derived: average of 2 quarters · filed 2023-03-30 | 14.82M shares derived: average of 3 quarters · filed 2023-03-30 | 14.82M shares 10-K · filed 2023-03-30 |
| 2021-09-30 | 14.82M shares 10-Q · filed 2022-11-14 | 14.82M shares derived: average of 2 quarters · filed 2022-11-14 | 14.82M shares 10-Q · filed 2022-11-14 | |
| 2021-06-30 | 14.82M shares 10-Q · filed 2022-08-11 | 14.82M shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |